(Q87450246)
Statements
Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor, decreases serum uric acid levels in type 2 diabetic patients partly by suppressing xanthine oxidase activity (English)
Sho-ichi Yamagishi
Yuji Ishibashi
Ayako Ojima
Tatsushi Sugiura